| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -3.7 | 0.2 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.45 | 0.02 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.34 | 1e-09 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.31 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.3 | 0.04 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.27 | 0.2 |